Advancements in Cellular Immunotherapies in the Immune Checkpoint Inhibitor Era for Cancer Treatment

Dear Colleagues,

The landscape of cancer treatment has undergone a remarkable transformation with the advent of immune checkpoint inhibitors (ICIs). These groundbreaking therapies have ushered in a new era in the fight against cancer by unleashing the power of the immune system to target and destroy malignant cells. Concurrently, cellular immunotherapies have emerged as a promising treatment frontier, offering personalized and precise approaches to combat this complex disease. Cell-mediated immunity can eliminate cancer cells and provide durable remissions. This Special Issue, entitled "Advancements in Cellular Immunotherapies in the Immune Checkpoint Inhibitor Era for Cancer Treatment," aims to provide a comprehensive overview of the latest developments in this dynamic field, including dendritic cell-based vaccines, whole-tumor-cell vaccines, and adoptive cell (T-cell, NK cell, or CAR-T cell) transfer.

Dr. Andrés Tittarelli
Dr. Flavio Salazar-Onfray
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.